drugset / Trial / NCT02498379

PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis (Volunteer - BioD and Safety Study)

NCT02498379 ↗

Phase 0 Completed 8 enrolled Washington University School of Medicine
NaSingle-groupOpen-labelDiagnostic

Summary

This study is designed to assess the safety, biodistribution and dosimetry of the novel atherosclerotic imaging PET radiotracer, Cu\[64\]-25%-CANF-Comb.

Timeline

Start
2014-10
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Cu[64]-25%CANF-Comb Diagnostic / imaging agent 148 mbq Intravenous
Subject Cu[64]-25%CANF-Comb Diagnostic / imaging agent 296 mbq Intravenous

Indications